Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@wisepress.bsky.socialOct 9, 2026, 8:48 AM

Wisepress will be at the ESMO Congress from πŸπŸ‘β€“πŸπŸ• πŽπœπ­π¨π›πžπ« πŸπŸŽπŸπŸ”, bringing our medical bookshop to the European Society for Medical Oncology community.

Stop by the Wisepress bookshop, have a browse and discover something new for your professional library.

#ESMO2026

@onclive.bsky.socialOct 6, 2026, 3:22 PM

WATCH πŸŽ₯: Alexis Ann LeVee, MD, previews the lidERA Breast Cancer PRO data being presented at the 2026 ESMO Congress. @myesmo.bsky.social #ESMO2026 #bcsm #oncology

Sign up to read the full preview ➑️: www.onclive.com/view/breast-...

@onclive.bsky.socialOct 6, 2026, 3:17 PM

WATCH πŸŽ₯: @kalinskykevin.bsky.social, of @winshipcancer.emory.edu, discusses key breast cancer abstracts being presented at the 2026 ESMO Congress. @myesmo.bsky.social #ESMO2026 #bcsm #oncology

Sign up to read our preview article for more insights ➑️: www.onclive.com/view/breast-...

@onc-rg.bsky.socialOct 2, 2026, 12:07 AM

π™π™π™š 2026 π™€π™Žπ™ˆπ™Š π™‡π˜½π˜Ό π™‡π™–π™£π™™π™¨π™˜π™–π™₯π™š: π™‘π™žπ™¨π™ͺπ™–π™‘π™žπ™―π™šπ™™.
Which mechanisms are commanding the late-breaker spotlight this year?

#ESMO2026 #ESMO26 #Oncology #NSCLC #SCLC #ADCs #vaccines #ClinicalData #DrugTrials #CompetitiveStrategy

Our analysts crunched the numbers across all LBAs:
βœ”οΈADCs lead the field β€” nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond
βœ”οΈCheckpoint inhibition isn't just a category β€” it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more
βœ”οΈBeyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO

Stay ahead of the competitive curve with verified insights.
Our analysts crunched the numbers across all LBAs:
βœ”οΈADCs lead the field β€” nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond
βœ”οΈCheckpoint inhibition isn't just a category β€” it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more
βœ”οΈBeyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO

Stay ahead of the competitive curve with verified insights.
@gmj-georgia.bsky.socialSep 28, 2026, 3:26 PM

πŸ”¬ A new investigational targeted therapy combined with standard chemotherapy has shown promise in advanced pancreatic cancer, according to early data … #Biomarkerdriventreatment #ESMO2026 #Oncology #Pancreaticcancer #Targetedtherapy #Biomarkerdriventreatment #ESMO2026 #Oncology #Pancreaticcance…

@breastcancerorg.bsky.socialSep 21, 2026, 4:46 PM

See which breast cancer studies we’re following ahead of this fall’s ESMO Congress: https://bit.ly/4ewhPCh

#BreastCancerNews #BreastCancerResearch #ESMO2026

@onc-rg.bsky.socialSep 18, 2026, 1:45 PM

Attending #ESMO2026 in Madrid? So is the ONCrg team!
Our oncology experts will be on the ground, analyzing the latest practice-changing clinical data, trial results, and emerging scientific insights as they unfold across over 20 tumor types.

#ESMO26 #Oncology #LungCancer #nsclc #sclc #ONCrg

@onc-rg.bsky.socialSep 18, 2026, 1:34 PM

Join our team as we break down the major readouts from WCLC 2026 and discuss what key signals to watch for as we head into ESMO 2026!
Register: events.teams.microsoft.com/event/681070...

#WCLC2026 #ESMO2026 #LungCancer #Oncology

ONCrg Live Event: WCLC Insights into ESMO Signals 
πŸ“… Date: Wednesday, Oct 7th at 1pm ET

Join our team as we break down the major readouts from WCLC 2026 and discuss what key signals to watch for as we head into ESMO 2026!

πŸ‘‡ What specific topics or questions are you hoping we cover during the live event? Let us know in the comments or when you register for the event!

#WCLC2026 #ESMO2026 #LungCancer #Oncology #clinicalinsights #competitiveintelligence #nsclc #sclc #oncrg #bprg